Skip to main content
Clinical Trials/ChiCTR2500100380
ChiCTR2500100380Not yet recruitingNot Applicable

基于“肠-肺”轴探讨微生物组学联合代谢组学在脓毒症急性肺损伤中的临床研究

自选课题(自筹)1 site in 1 countryStarted: February 20, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Locations
1
Primary Endpoint
微生物组与代谢组数据

Study Overview

Brief Summary

揭示“肠-肺”轴在脓毒症 ALI 中的具体作用机制,明确肠道菌群与代谢物是否可作为脓毒症 ALI 诊断或治疗的潜在靶点,为临床干预提供新思路

Study Design

Study Type
观察性研究
Primary Purpose
横断面
Masking
无

Eligibility Criteria

Ages
18 to 75 (—)
Sex
All

Inclusion Criteria

  • •1.根据《脓毒症的诊断和管理指南》符合脓毒症的诊断标准;
  • •2.具备急性肺损伤特征:低氧血症(动脉血氧分压(PaO2)/吸入氧浓度(FiO2) 比值≤<=300 mmHg);
  • •3.肺部影像学改变(胸部影像显示双侧浸润影,如 X 光或 CT 检查);
  • •4.无其他明确原因导致的肺损伤;
  • •5.签署知情同意书,同意参与本研究。

Exclusion Criteria

  • •1.妊娠或哺乳期妇女;
  • •2.合并其它重大疾病(如晚期癌症、严重免疫缺陷等);

Arms & Interventions

脓毒症 ALI 疾病组

Intervention: 脓毒症 ALI 疾病组

脓毒症非 ALI 疾病组

Intervention: 脓毒症非 ALI 疾病组

健康对照组

Intervention: 健康对照组

Outcomes

Primary Outcomes

微生物组与代谢组数据

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
自选课题(自筹)

Study Sites (1)

Loading locations...

Similar Trials